Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.
Carnero Contentti E, Delgado-García G, Criniti J, López PA, Pettinicchi JP, Cristiano E, Miguez J, Correa-Díaz EP, Álvarez Pucha MO, Miño Zambrano JE, Gómez-Figueroa E, Rivas-Alonso V, Flores-Rivera J, Tkachuk V, Caride A, Rojas JI. Carnero Contentti E, et al. Front Immunol. 2021 Feb 23;12:628024. doi: 10.3389/fimmu.2021.628024. eCollection 2021. Front Immunol. 2021. PMID: 33717149 Free PMC article.
Opisthotonus (arc de cercle) in anti-NMDAR encephalitis.
Delgado-García G, Cano-Nigenda V, Abundes-Corona A, Carrillo-Loza K, Calleja-Castillo J, Flores-Rivera J. Delgado-García G, et al. Arq Neuropsiquiatr. 2018 Jun;76(6):426. doi: 10.1590/0004-282X20180047. Arq Neuropsiquiatr. 2018. PMID: 29972427 Free article. No abstract available.
Neurocysticercosis: mimics and chameleons.
Delgado-García G, Méndez-Zurita VA, Bayliss L, Flores-Rivera J, Fleury A. Delgado-García G, et al. Pract Neurol. 2019 Apr;19(2):88-95. doi: 10.1136/practneurol-2017-001788. Epub 2018 Oct 3. Pract Neurol. 2019. PMID: 30282762 Review.
Severe fingolimod rebound syndrome after switching to cladribine treatment.
Coss-Rovirosa F, Salado-Burbano J, Casallas-Vanegas A, Caire-Herrera LE, Gómez-Figueroa E, Flores-Rivera J. Coss-Rovirosa F, et al. Mult Scler Relat Disord. 2020 May;40:101938. doi: 10.1016/j.msard.2020.101938. Epub 2020 Jan 16. Mult Scler Relat Disord. 2020. PMID: 31982666
Effect of rituximab on disease activity in latin American patients with anti-aquaporin-4 (+) neuromyelitis optica spectrum disorder.
Gomez-Figueroa E, Noriega-Morales G, Casallas-Vanegas A, Zabala-Angeles I, Garcia-Estrada C, Neri D, Sarachaga AJ, Rivas-Alonso V, Corona-Vazquez T, Flores-Rivera J. Gomez-Figueroa E, et al. Clin Neurol Neurosurg. 2020 Sep;196:106007. doi: 10.1016/j.clineuro.2020.106007. Epub 2020 Jun 9. Clin Neurol Neurosurg. 2020. PMID: 32559706
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice.
Carnero Contentti E, Rojas JI, Cristiano E, Marques VD, Flores-Rivera J, Lana-Peixoto M, Navas C, Papais-Alvarenga R, Sato DK, Soto de Castillo I, Correale J. Carnero Contentti E, et al. Mult Scler Relat Disord. 2020 Oct;45:102428. doi: 10.1016/j.msard.2020.102428. Epub 2020 Jul 29. Mult Scler Relat Disord. 2020. PMID: 32763842 Review.
63 results